Corporations: Reply to Cochrane

The Authors’ Reply

Multinational corporations.

"Is Cybermedicine Killing You?" - A Response From the Authors of the Cochrane Review: Author's Reply (2)

We thank Murray and colleagues for adding their view to the "series of unfortunate events" outlined in the editorial [1] and in Rada's paper [2]. The editorial accurately describes the swift response of the authors in retracting the review within 13 days — unfortunately, at this time the cat was already out of the bag, and the media coverage had been substantial. We still think that, in order t...

The Authors’ Reply

Reply to the Letter to the Editor Reply to

We thank Dr Schachner for his interest and comments on our recent experimental findings [1]. The first facet of our study was that although initially (at 1 month), neointima formation in vein grafts was inhibited by perivenous application of fibrin glue at the time of implantation, at 4 months neointimal formation was not significantly different from controls [1]. Dr Schachner has implied that ...